Legal & General Group PLC Collegium Pharmaceutical, Inc Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Legal & General Group PLC holds 94,168 shares of COLL stock, worth $3.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,168

Previous 91,568 2.84%

Holding current value

$3.6 Million

Previous $3.55 Million 14.69%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$31.36 - $39.99 $81,536 - $103,974	2,600 Added 2.84%	94,168 $3.03 Million
Q1 2024 May 14, 2024	SELL	$31.23 - $40.91 $58,150 - $76,174	-1,862 Reduced 1.99%	91,568 $3.55 Million
Q4 2023 Feb 15, 2024	SELL	$21.16 - $30.8 $92,998 - $135,366	-4,395 Reduced 4.49%	93,430 $2.88 Million
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $100,630 - $115,087	4,740 Added 5.09%	97,825 $2.19 Million
Q2 2023 Aug 14, 2023	BUY	$21.06 - $24.0 $269,947 - $307,632	12,818 Added 15.97%	93,085 $2 Million
Q1 2023 May 15, 2023	SELL	$23.0 - $29.88 $23,943 - $31,105	-1,041 Reduced 1.28%	80,267 $1.93 Million
Q4 2022 Feb 14, 2023	BUY	$16.14 - $23.55 $14,509 - $21,171	899 Added 1.12%	81,308 $1.89 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $3,262 - $4,241	211 Added 0.26%	80,409 $1.29 Million
Q2 2022 Aug 22, 2022	SELL	$14.22 - $20.88 $11,887 - $17,455	-836 Reduced 1.03%	80,198 $1.42 Million
Q1 2022 May 16, 2022	SELL	$17.2 - $22.5 $7,361 - $9,630	-428 Reduced 0.53%	81,034 $1.65 Million
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $12,845 - $15,670	734 Added 0.91%	81,462 $1.52 Million
Q3 2021 Nov 15, 2021	BUY	$17.75 - $25.39 $122,670 - $175,470	6,911 Added 9.36%	80,728 $1.59 Million
Q2 2021 Aug 12, 2021	SELL	$21.74 - $25.28 $510,868 - $594,054	-23,499 Reduced 24.15%	73,817 $1.75 Million
Q1 2021 May 17, 2021	BUY	$19.25 - $26.1 $1.76 Million - $2.39 Million	91,500 Added 1573.25%	97,316 $2.31 Million
Q4 2020 Feb 12, 2021	SELL	$17.83 - $22.29 $909 - $1,136	-51 Reduced 0.87%	5,816 $116,000
Q3 2020 Nov 13, 2020	SELL	$15.78 - $20.82 $24,474 - $32,291	-1,551 Reduced 20.91%	5,867 $123,000
Q2 2020 Aug 14, 2020	BUY	$15.49 - $23.51 $26,580 - $40,343	1,716 Added 30.09%	7,418 $130,000
Q1 2020 May 14, 2020	SELL	$13.89 - $25.45 $19,737 - $36,164	-1,421 Reduced 19.95%	5,702 $93,000
Q4 2019 Feb 13, 2020	BUY	$10.7 - $22.24 $13,310 - $27,666	1,244 Added 21.16%	7,123 $146,000
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $6,733 - $10,518	634 Added 12.09%	5,879 $78,000
Q4 2018 Feb 15, 2019	BUY	$14.78 - $19.68 $5,527 - $7,360	374 Added 7.68%	5,245 $91,000
Q2 2018 Aug 10, 2018	BUY	$21.79 - $28.29 $10,720 - $13,918	492 Added 11.24%	4,871 $116,000
Q1 2018 May 17, 2018	SELL	$18.15 - $29.21 $33,867 - $54,505	-1,866 Reduced 29.88%	4,379 $112,000
Q4 2017 Feb 13, 2018	BUY	$9.3 - $19.14 $58,078 - $119,529	6,245	6,245 $116,000

Others Institutions Holding COLL

# of Institutions

236

Shares Held

39.4M

Call Options Held

84.2K

Put Options Held

18.6K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.31B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Collegium Pharmaceutical, Inc Transaction History